Scopia Capital to inject up to $60mn into struggling R&Q
London-listed R&Q has hailed a deal with one of its new shareholders to inject $50mn+ into the business as a significant step in splitting its struggling legacy arm from its fast-growing MGA fronting business Accredited.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below